Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

The techniques and tricks may have changed over the years, but when it comes to the ways in which scammers separate you from ...

You can actually stave them off with one very simple solution, and that means kissing "Possible Spam" (without any legitimate name, of course) goodbye. And who hasn't wanted to do that in their ...